Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,816 | 24,411 | 40,580 | 48,534 | 53,407 |
| Marketable Securities | 34,513 | 122,273 | 114,375 | 88,609 | 54,972 |
| Receivables | 56,041 | 49,945 | 51,763 | 45,925 | 39,907 |
| Inventories | 14,367 | 11,652 | 11,506 | 13,303 | 10,423 |
| TOTAL | $185,529 | $234,027 | $240,166 | $214,927 | $175,393 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 54 | 57 |
| Intangibles | 93,878 | 24,160 | 24,748 | 25,336 | 25,924 |
| Other Non-Current Assets | 241,659 | 246,421 | 248,680 | 2,217 | 5,362 |
| TOTAL | $335,537 | $270,581 | $273,428 | $27,607 | $31,343 |
| Total Assets | $521,066 | $504,608 | $513,594 | $242,534 | $206,736 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,011 | 4,486 | 7,191 | 3,846 | 7,290 |
| Accrued Expenses | 15,543 | 11,751 | 17,438 | 14,881 | 12,018 |
| Other current liabilities | 28,192 | 33,080 | 32,716 | 35,020 | 34,502 |
| TOTAL | $95,586 | $89,492 | $99,237 | $94,400 | $86,636 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 14,991 | 22,482 | 29,969 | 37,452 |
| Deferred Revenues | N/A | N/A | N/A | 1,355 | 1,355 |
| Other Non-Current Liabilities | 58 | 228 | 395 | 556 | 714 |
| TOTAL | $58 | $15,219 | $22,877 | $30,525 | $38,166 |
| Total Liabilities | $95,644 | $104,711 | $122,114 | $124,925 | $124,802 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,680 | 18,502 | 18,473 | 18,151 | 17,937 |
| Common Shares | 18 | 18 | 18 | 18 | 18 |
| Retained earnings | -997,097 | -1,014,387 | -1,023,041 | -1,291,106 | -1,319,006 |
| Other shareholders' equity | -148 | -128 | 181 | 96 | 6 |
| TOTAL | $425,422 | $399,897 | $391,480 | $117,609 | $81,934 |
| Total Liabilities And Equity | $521,066 | $504,608 | $513,594 | $242,534 | $206,736 |